Nature Communications

Faecalibacterium prausnitzii EXL01 for the Maintenance of Steroid-induced Clinical Response or Remission in Patients with Crohn’s Disease: a first in human trial

2026-04-28

Full text

DOI https://doi.org/10.1038/s41467-026-72375-y